Psychonautic Ethos

 External Links:

  Why Sentia by GABA Labs May Violate DSHEA Guidelines: A Closer Look at Psychoactive Claims Introduction In recent years,  Sentia  by GABA Labs has garnered attention in the United States as a purported “alcohol alternative” beverage that promotes relaxation or mood enhancement. While marketed under the umbrella of dietary supplements, the product’s emphasis on psychoactive effects raises important regulatory questions under the  Dietary Supplement Health and Education Act (DSHEA) . This article explores how  Sentia  may be crossing the line from lawful dietary supplement to an unapproved new drug, based on U.S. Food and Drug Administration (FDA) standards—and how GABA Labs’ own published content referencing outside psychoactive claims could invite regulatory scrutiny. DSHEA Basics and the FDA’s Position Under DSHEA (1994), dietary supplements are not subject to the same  premarket approval  that drugs require. Nonetheless, they must adhere to st...